Phase 3 trials of oral tavapadon in easing motor symptoms nearing end
An ongoing and global Phase 3 clinical trial program for oral tavapadon, a selective dopamine receptor agonist…
Articles by Patricia Inácio, PhD
Enrollment now complete for Phase 2 PROSEEK study of vodobatinib
Enrollment is now complete for a Phase 2 trial that’s assessing the safety and efficacy of oral vodobatinib (K0706), an…
Trial on way to increase exercise for Hispanic patients now recruiting
A trial investigating the feasibility and impact of a novel approach for increasing regular exercise among Hispanic people with…
ABBV-951 now available at low, no cost in England to certain patients
ABBV-951 (foslevodopa/foscarbidopa) — Abbvie’s continuous infusion formulation of levodopa/carbidopa that’s administered under the skin — will now be…
New Parkinson’s research center launched at Yale School of Medicine
The Yale School of Medicine has announced it will launch the Stephen and Denise Adams Center for Parkinson’s Disease Research,…
Asha Therapeutics selected to join Blue Knight for public health
Asha Therapeutics has been selected as a Blue Knight company, joining a public-private initiative that focuses on speeding new…
Blood test may help with early diagnosis, before symptoms start
A new blood test that assesses damage on a particular type of DNA may help in the early diagnosis of…
NE3107, alone or with levodopa, may lead to motor function gains
NE3107, BioVie’s experimental oral therapy for Parkinson’s disease, is showing promise as a first-line therapy to ease motor…
Aspen to collect patient data remotely before its cell therapy trial
Aspen Neuroscience will use Rune Labs’ digital health platform to remotely collect data from Parkinson’s disease patients…
Project working to improve speech recognition software seeks patients
The Speech Accessibility Project continues to seek participants for its initiative, which focuses on enhancing voice recognition software for…